This study investigated the effectiveness of cetuximab (Erbitux) in combination with chemotherapy for the treatment of advanced colorectal cancer (CRC). Researchers suggested that this combined treatment improves the outcomes of patients with CRC.

This study investigated the effectiveness of high completion of irinotecan (Camptosar) chemotherapy before locally advanced rectal cancer surgery. Researchers suggested that the completion of irinotecan chemotherapy was associated with better tumor response in these patients.

This study investigated whether tummy infections (TIs) after surgery are associated with colorectal cancer outcomes. Researchers suggested that TIs might be associated with a shorter time until recurrence.

This study investigated the changes in fatigue (tiredness) severity in patients with rectal cancer undergoing treatment. Researchers suggested that fatigue gradually improves after treatment in these patients. 

This study investigated whether bevacizumab (Avastin) therapy and surgery of the tumor can improve the outcomes of patients with advanced colorectal cancer (CRC). Researchers suggested that patients treated with bevacizumab have better outcomes when undergoing surgery.

This study investigated the role and optimal dose and duration of adjuvant (after surgery) chemotherapy (AC) in patients with locally advanced rectal cancer. Researchers suggested that this treatment was associated with improved survival in these patients.

This study investigated if laparoscopic surgery (LS) is associated with fewer complications in colorectal cancer compared to classic, open surgery. Researchers suggested that LS decreases the odds of having a complication after colorectal cancer surgery. 

This study examined the effects of granulocyte colony-stimulating factor (G-CSF) given as a preventative measure in patients with high- and medium-risk cancer receiving chemotherapy. The results showed that preventative G-CSF allowed more patients to complete chemotherapy treatment and lowered patients’ chances of developing secondary tumors.

This study investigated the effectiveness of cytoreductive surgery (CRS) in patients with colorectal cancer spread to the peritoneum (inner lining of the abdominal cavity). Researchers suggested that CRS is associated with improved survival in these patients.

This study investigated the safety and effectiveness of TAS-102 (trifluridine-tipiracil) with and without bevacizumab (Avastin) therapy in metastatic colorectal cancer (mCRC). Researchers suggested that this combined therapy might be a good treatment option for patients with advanced CRC.